112 results match your criteria: "Centre Hospitalier de Luxembourg CHL[Affiliation]"
Clin Neurophysiol
June 2016
Department of Neurodegenerative Diseases and Hertie Institute for Clinical Brain Research (HIH), University of Tuebingen, Tuebingen, Germany; German Centre of Neurodegenerative Diseases (DZNE), University of Tuebingen, Tuebingen, Germany; Centre for Integrative Neuroscience (CIN), University of Tuebingen, Tuebingen, Germany. Electronic address:
Objective: Freezing behavior is an unmet symptom in Parkinson's disease (PD), which reflects its complex pathophysiology. Freezing behavior can emerge when attentional capacity is reduced, i.e.
View Article and Find Full Text PDFPLoS One
May 2016
Competence Center in Methodology and Statistics, Luxembourg Institute of Health (LIH), Strassen, Luxembourg.
Objectives: This study aimed to assess the prevalence of dementia and cognitive complaints in a cross-sectional sample of Luxembourg seniors, and to discuss the results in the societal context of high cognitive reserve resulting from multilingualism.
Methods: A population sample of 1,377 people representative of Luxembourg residents aged over 64 years was initially identified via the national social insurance register. There were three different levels of contribution: full participation in the study, partial participation, and non-participation.
PLoS One
April 2016
Laboratory of Experimental Hemato-Oncology, LHCE, Luxembourg Institute of Health (LIH), Strassen, Luxembourg; Laboratory of Hematology, Centre Hospitalier de Luxembourg (CHL), Strassen, Luxembourg.
Epigenetic modifications play a major role in the development of multiple myeloma. We have previously reported that the PPARγ agonist pioglitazone (PIO) enhances, in-vitro, the cytotoxic effect of the Histone deacetylase inhibitor (HDACi), valproic acid (VPA), on multiple myeloma cells. Here, we described the development of a new multiple myeloma mouse model using MOLP8 cells, in order to evaluate the effect of VPA/PIO combination on the progression of myeloma cells, by analyzing the proliferation of bone marrow plasma cells.
View Article and Find Full Text PDFClin Neurophysiol
January 2016
Department of Neurodegenerative Diseases and Hertie Institute for Clinical Brain Research (HIH), University of Tuebingen, Germany; German Centre of Neurodegenerative Diseases (DZNE), University of Tuebingen, Tuebingen, Germany; Centre for Integrative Neuroscience (CIN), University of Tuebingen, Tuebingen, Germany. Electronic address:
Objective: The pathophysiology of deep brain stimulation mechanisms and resistant freezing phenomena in idiopathic Parkinson's disease (iPD) remains incompletely understood. Further studies on the neuromuscular substrates are needed.
Methods: We analyzed 16 patients with advanced iPD and bilateral subthalamic nucleus stimulation, and 13 age- and gender-matched healthy controls.
J Tissue Eng Regen Med
April 2017
Department of Experimental Trauma Surgery, Klinikum Rechts der Isar, Technical University Munich, Germany.
Synthetic graft materials are considered as possible substitutes for cancellous bone, but lack osteogenic and osteoinductive properties. In this study, we investigated how composite scaffolds of βTCP containing osteogenic human bone marrow mesenchymal stem cells (hBMSCs) and osteoinductive bone morphogenetic protein-2 (BMP-2) influenced the process of fracture healing. hBMSCs were loaded into βTCP scaffolds 24 h before implantation in a rat critical-sized bone defect.
View Article and Find Full Text PDFAnn Clin Transl Neurol
January 2015
Luxembourg Centre for Systems Biomedicine (LCSB) Esch-sur-Alzette, Luxembourg ; Centre Hospitalier de Luxembourg (CHL) Luxembourg City, Luxembourg.
Objective: Mitochondrial dysfunction is a hallmark of idiopathic Parkinson's disease (IPD), which has been reported not to be restricted to striatal neurons. However, studies that analyzed mitochondrial function at the level of selected enzymatic activities in peripheral tissues have produced conflicting data. We considered the electron transport chain as a complex system with mitochondrial membrane potential as an integrative indicator for mitochondrial fitness.
View Article and Find Full Text PDFParkinsonism Relat Disord
March 2015
German Centre of Neurodegenerative Diseases (DZNE), Tübingen, Germany; Department for Neurodegenerative Diseases and Hertie Institute for Clinical Brain Research, University of Tübingen, Germany; Werner Reichardt Centre for Integrative Neuroscience, Tübingen, Germany; Clinical and Experimental Neuroscience, Luxembourg Center for Systems Biomedicine (LCSB), University of Luxembourg and Centre Hospitalier de Luxembourg (CHL), Luxembourg. Electronic address:
Introduction: Fragile X-associated tremor/ataxia syndrome (FXTAS) presents as complex movement disorder including tremor and cerebellar ataxia. The efficacy and safety of deep brain stimulation of the nucleus ventralis intermedius of the thalamus in atypical tremor syndromes like FXTAS remains to be determined.
Methods: Here, we report the long-term outcome of three male genetically confirmed FXTAS patients treated with bilateral neurostimulation of the nucleus ventralis intermedius for up to four years.
Brain
March 2015
3 Werner Reichardt Centre for Integrative Neuroscience, 72076 Tübingen, Germany 5 Division of Functional and Restorative Neurosurgery, Department of Neurosurgery, University of Tübingen, 72076 Tübingen, Germany
Dynamic modulations of large-scale network activity and synchronization are inherent to a broad spectrum of cognitive processes and are disturbed in neuropsychiatric conditions including Parkinson's disease. Here, we set out to address the motor network activity and synchronization in Parkinson's disease and its modulation with subthalamic stimulation. To this end, 20 patients with idiopathic Parkinson's disease with subthalamic nucleus stimulation were analysed on externally cued right hand finger movements with 1.
View Article and Find Full Text PDFBull Soc Sci Med Grand Duche Luxemb
March 2014
Institute for Health Promotion, ZithaGesondheetsZentrum (ZGZ),36 rue Zithe, L-2763 Luxembourg, Luxembourg.
There is no doubt that a healthy diet and regular physical activity improve risk factors for cerebro-cardio-vascular disease and death. However, there is less evidence from prospective randomised controlled trials that they also reduce the actual risk of stroke, myocardial infarction and death. The only evidence from randomised controlled trials is, that a mediterranean diet with nuts and/or native olive oil considerably reduces stroke risk by 47% respectively 31%, however not the risk of myocardial infarction and death.
View Article and Find Full Text PDFNutr J
November 2013
Department of Neurology, Centre Hospitalier de Luxembourg (CHL), 4 rue Barblé, L-1210, Luxembourg, Luxemburg.
Background: Physical exercise and a Mediterranean diet improve serum lipid profile. The present work studied whether red wine has an effect on top of a lipid-lowering lifestyle in patients with carotid atherosclerosis.
Methods: A prospective randomised unblinded trial was performed from 2009 to 2011 in 108 patients with carotid atherosclerosis, 65% of whom were already on statin therapy with a low mean LDL of 104.
Bull Soc Sci Med Grand Duche Luxemb
July 2013
Department of Neurology, Centre Hospitalier de Luxembourg (CHL), 4 rue Barblé, L-1210 Luxembourg, Luxemburg.
Background: Healthy diet and physical activity improve risk factors for cerebrovascular disease. It is unclear whether patients with carotid artery disease from Luxemburg meet common guideline criteria and whether systematic counseling has a sustained effect.
Methods: We assessed anthropometric data, eating habits and physical activity habits in 53 patients with carotid atherosclerosis at baseline, after 4 and 20 weeks, and advised them five times for 30 min to follow a modified Mediterranean diet and to perform moderate physical exercise at least during 30 min/day.
Bull Soc Sci Med Grand Duche Luxemb
July 2009
Service de Cardiologie, Centre Hospitalier de Luxembourg (CHL), 4, rue E. Barblé, L-1210 Luxembourg.
An Antiphospholipid syndrome (APS) was diagnosed in a patient who had massive pulmonary embolisation from a right atrial thrombus. The (APS) is an autoimmune disease defined by the presence in the serum of at least one type of autoantibody known as antiphospholipid antibody (aPL) and the occurrence of at least one clinical feature from a list of potential disease manifestations, the most common of which are venous or arterial thrombosis, recurrent fetal loss and thrombocytopenia. The prevalence of APS in a series of patients from internal medicine is 2 percent.
View Article and Find Full Text PDF